PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19 June 17, 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring Assays for Minimal Residual Disease May 26, 2020
Bayer and ArcherDX Announce Global Collaboration to Develop Next-Generation Sequencing-based Companion Diagnostic for VITRAKVI May 15, 2020
